Literature DB >> 17131422

Treatment of thyroid cancer based on risk groups.

Ashok Shaha1.   

Abstract

The understanding of the prognostic factors and risk groups is crucial in the management of well differentiated thyroid cancer. The important prognostic factors are age, grade of tumor, extrathyroidal extension, size of tumor, and distant metastases. Based on these prognostic factors, patients can be divided into low-, intermediate-, and high-risk groups. The treatment decisions should be based on risk group analysis. Extent of thyroidectomy and adjuvant therapy can be based on the risk group analysis. The histopathologic studies are very important to distinguish well differentiated from the tall cell, insular, and poorly differentiated thyroid cancer.

Entities:  

Mesh:

Year:  2006        PMID: 17131422     DOI: 10.1002/jso.20697

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  18 in total

1.  Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer.

Authors:  Daniel Mankarios; Peter Baade; Pip Youl; Robin H Mortimer; Adedayo A Onitilo; Anthony Russell; Suhail A R Doi
Journal:  Endocrine       Date:  2013-10-31       Impact factor: 3.633

2.  Thyroid gland: Can a nomogram predict death in patients with thyroid cancer?

Authors:  Tracy S Wang; Julie A Sosa
Journal:  Nat Rev Endocrinol       Date:  2013-03-05       Impact factor: 43.330

Review 3.  Optimal differentiated thyroid cancer management in the elderly.

Authors:  Donald S A McLeod; Kelly Carruthers; Dev A S Kevat
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

Review 4.  Management of thyroid nodules and surgery for differentiated thyroid cancer.

Authors:  N G Iyer; A R Shaha
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-04-08       Impact factor: 4.126

5.  Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer.

Authors:  Ashok R Shaha; Jocelyn C Migliacci; Iain J Nixon; Laura Y Wang; Richard J Wong; Luc G T Morris; Snehal G Patel; Jatin P Shah; R Michael Tuttle; Ian Ganly
Journal:  Surgery       Date:  2018-11-08       Impact factor: 3.982

6.  Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases.

Authors:  Alexandre Bozec; Olivier Dassonville; Emmanuel Chamorey; Gilles Poissonnet; Anne Sudaka; Isabelle Peyrottes; Francette Ettore; Juliette Haudebourg; Françoise Bussière; Danielle Benisvy; Pierre-Yves Marcy; Jean Louis Sadoul; Paul Hofman; Sandra Lassale; Jacques Vallicioni; François Demard; José Santini
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-05-24       Impact factor: 2.503

7.  Pattern of regional metastases and prognostic factors in differentiated thyroid carcinoma.

Authors:  G Spriano; P Ruscito; R Pellini; M Appetecchia; R Roselli
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-12       Impact factor: 2.124

8.  Clinical significance of Delphian lymph node metastasis in papillary thyroid carcinoma.

Authors:  Eun Mee Oh; Yoo Seung Chung; Young Don Lee
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

9.  Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas.

Authors:  Johanna Wassermann; Marie-Odile Bernier; Jean-Philippe Spano; Charlotte Lepoutre-Lussey; Camille Buffet; Jean-Marc Simon; Fabrice Ménégaux; Frédérique Tissier; Monique Leban; Laurence Leenhardt
Journal:  Oncologist       Date:  2015-12-16

10.  Comment on "The Diagnosis and Management of Thyroid Nodules: A Review".

Authors:  Ashok R Shaha
Journal:  Gland Surg       Date:  2018-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.